Drug Profile
Secnidazole - Lupin
Alternative Names: Solosec; SYM-1219Latest Information Update: 28 Feb 2022
Price :
$50
*
At a glance
- Originator Symbiomix Therapeutics
- Developer Lupin; Symbiomix Therapeutics
- Class Antibacterials; Antiprotozoals; Nitroimidazoles; Propanols; Small molecules
- Mechanism of Action DNA synthesis inhibitors; Free radical stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Bacterial vaginosis; Trichomoniasis